{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:12:50Z","timestamp":1787242370190,"version":"build-2736575974"},"reference-count":23,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T00:00:00Z","timestamp":1436140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100015699","name":"Fresenius Medical Care","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015699","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Artificial Organs"],"published-print":{"date-parts":[[2016,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Peritoneal transport characteristics and residual renal function require regular control and subsequent adjustment of the peritoneal dialysis (\n                    <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\n                    ) prescription. Prescription models shall facilitate the prediction of the outcome of such adaptations for a given patient. In the present study, the prescription model implemented in the PatientOnLine software was validated in patients requiring a prescription change. This multicenter, international prospective cohort study with the aim to validate a\n                    <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\n                    prescription model included patients treated with continuous ambulatory peritoneal dialysis. Patients were examined with the peritoneal function test (\n                    <jats:styled-content style=\"fixed-case\">PFT<\/jats:styled-content>\n                    ) to determine the outcome of their current prescription and the necessity for a prescription change. For these patients, a new prescription was modeled using the PatientOnLine software (Fresenius Medical Care, Bad Homburg, Germany). Two to four weeks after implementation of the new\n                    <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\n                    regimen, a second\n                    <jats:styled-content style=\"fixed-case\">PFT<\/jats:styled-content>\n                    was performed. The validation of the prescription model included 54 patients. Predicted and measured peritoneal\n                    <jats:styled-content style=\"fixed-case\">Kt\/V<\/jats:styled-content>\n                    were 1.52\u2009\u00b1\u20090.31 and 1.66\u2009\u00b1\u20090.35, and total (peritoneal\u2009+\u2009renal)\n                    <jats:styled-content style=\"fixed-case\">Kt\/V<\/jats:styled-content>\n                    values were 1.96\u2009\u00b1\u20090.48 and 2.06\u2009\u00b1\u20090.44, respectively. Predicted and measured peritoneal creatinine clearances were 42.9\u2009\u00b1\u20098.6 and 43.0\u2009\u00b1\u20098.8\u2009L\/1.73\u2009m\n                    <jats:sup>2<\/jats:sup>\n                    \/week and total creatinine clearances were 65.3\u2009\u00b1\u200926.0 and 63.3\u2009\u00b1\u200921.8\u2009L\/1.73\u2009m\n                    <jats:sup>2<\/jats:sup>\n                    \/week, respectively. The analysis revealed a\n                    <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>\n                    earson's correlation coefficient for peritoneal\n                    <jats:styled-content style=\"fixed-case\">Kt\/V<\/jats:styled-content>\n                    of 0.911 and\n                    <jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>\n                    in's concordance coefficient of 0.829. The value of both coefficients was 0.853 for peritoneal creatinine clearance. Predicted and measured daily net ultrafiltration was 0.77\u2009\u00b1\u20090.49\u2009and 1.16\u2009\u00b1\u20090.63\u2009L\/24\u2009h, respectively.\n                    <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>\n                    earson's correlation and\n                    <jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>\n                    in's concordance coefficient were 0.518 and 0.402, respectively. Predicted and measured peritoneal glucose absorption was 125.8\u2009\u00b1\u200938.8 and 79.9\u2009\u00b1\u200930.7\u2009g\/24\u2009h, respectively, and\n                    <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>\n                    earson's correlation and\n                    <jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>\n                    in's concordance coefficient were 0.914 and 0.477, respectively. With good predictability of peritoneal\n                    <jats:styled-content style=\"fixed-case\">Kt\/V<\/jats:styled-content>\n                    and creatinine clearance, the present model provides support for individual dialysis prescription in clinical practice. Peritoneal glucose absorption and ultrafiltration are less predictable and are likely to be influenced by additional clinical factors to be taken into consideration.\n                  <\/jats:p>","DOI":"10.1111\/aor.12526","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T05:38:08Z","timestamp":1436161088000},"page":"144-152","source":"Crossref","is-referenced-by-count":4,"title":["Clinical Validation of a Peritoneal Dialysis Prescription Model in the\n                    <scp>P<\/scp>\n                    atient\n                    <scp>O<\/scp>\n                    n\n                    <scp>L<\/scp>\n                    ine Software"],"prefix":"10.1111","volume":"40","author":[{"given":"Emir","family":"Hodzic","sequence":"first","affiliation":[{"name":"Clinic for Internal Diseases University Clinical Center  Tuzla Bosnia and Herzegovina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senija","family":"Rasic","sequence":"additional","affiliation":[{"name":"Clinical Center University  Sarajevo Bosnia and Herzegovina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Klein","sequence":"additional","affiliation":[{"name":"Dr. Carol Davila Hospital  Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Covic","sequence":"additional","affiliation":[{"name":"University of Medicine \u201cGrigore T Popa\u201d  Iasi Romania"},{"name":"\u201cC. I. Parhon\u201d University Hospital  Iasi Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulkadir","family":"Unsal","sequence":"additional","affiliation":[{"name":"Sisli Etfal Hospital  Istanbul Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel Gil","family":"Cunquero","sequence":"additional","affiliation":[{"name":"General Hospital  Jaen Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich C.","family":"Prischl","sequence":"additional","affiliation":[{"name":"Klinikum Wels\u2010Grieskirchen  Wels Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelheid","family":"Gauly","sequence":"additional","affiliation":[{"name":"Fresenius Medical Care  Bad Homburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Kalicki","sequence":"additional","affiliation":[{"name":"University Hospital  Bern Switzerland"},{"name":"University of Bern  Bern Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik E.","family":"Uehlinger","sequence":"additional","affiliation":[{"name":"University Hospital  Bern Switzerland"},{"name":"University of Bern  Bern Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,7,6]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq100"},{"key":"e_1_2_9_3_1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/089686080602600502","article-title":"Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis","volume":"26","author":"Lo WK","year":"2006","journal-title":"Perit Dial Int"},{"issue":"9","key":"e_1_2_9_4_1","first-page":"ix24","article-title":"European best practice guidelines for peritoneal dialysis. 7 Adequacy of peritoneal dialysis","volume":"20","author":"Dombros N","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1351307"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00098.x"},{"key":"e_1_2_9_7_1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/089686080902900609","article-title":"Peritoneal small solute clearance is nonlinearly related to patient survival in the Australian and New Zealand peritoneal dialysis patient populations","volume":"29","author":"Rumpsfeld M","year":"2009","journal-title":"Perit Dial Int"},{"key":"e_1_2_9_8_1","first-page":"43","article-title":"Computerized urea kinetic modeling to prescribe and monitor delivered Kt\/V (pKt\/V, dKt\/V) in peritoneal dialysis. Fresenius Randomized Dialysis Prescriptions and Clinical Outcome Study (RDP\/CO)","volume":"12","author":"Gotch FA","year":"1996","journal-title":"Adv Perit Dial"},{"issue":"2","key":"e_1_2_9_9_1","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1177\/089686089701702S24","article-title":"PACK PD: a urea kinetic modeling computer program for peritoneal dialysis","volume":"17","author":"Gotch FA","year":"1997","journal-title":"Perit Dial Int"},{"issue":"2","key":"e_1_2_9_10_1","first-page":"S141","article-title":"Peritoneal function test as a basis for assessment of adequate therapy and for urea kinetic modelling","volume":"23","author":"Keen ML","year":"1994","journal-title":"Nieren und Hochdruckkrankh"},{"key":"e_1_2_9_11_1","first-page":"303","article-title":"A formula to estimate the approximate surface area if height and weight be known. 1916","volume":"5","author":"Du Bois D","year":"1989","journal-title":"Nutrition"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/33.1.27"},{"key":"e_1_2_9_13_1","first-page":"343","volume-title":"Clinical Dialysis","author":"Gotch FA","year":"1995"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.2307\/2532051"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.AACN.0000318125.41512.a3"},{"key":"e_1_2_9_16_1","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1681\/ASN.V4101820","article-title":"Relationship between body size, fill volume, and mass transfer area coefficient in peritoneal dialysis","volume":"4","author":"Keshaviah P","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_9_17_1","first-page":"633","article-title":"Peritoneal transport testing","volume":"23","author":"La Milia V","year":"2010","journal-title":"J Nephrol"},{"key":"e_1_2_9_18_1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/089686089901900611","article-title":"A multinational clinical validation study of PD ADEQUEST 2.0. PD ADEQUEST International Study Group","volume":"19","author":"Vonesh EF","year":"1999","journal-title":"Perit Dial Int"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi344"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.66021.x"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017148"},{"key":"e_1_2_9_22_1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/089686080602600408","article-title":"Overfill or ultrafiltration? We need to be clear","volume":"26","author":"Davies SJ","year":"2006","journal-title":"Perit Dial Int"},{"key":"e_1_2_9_23_1","unstructured":"EDTNA\/ERCA.European Guidelines for the Nutritional Care of Adult Renal Patients. Dietitians Special Interest Group October.2002."},{"key":"e_1_2_9_24_1","first-page":"131","article-title":"A simple kinetic model for assessing peritoneal mass transfer in chronic ambulatory peritoneal dialysis","volume":"6","author":"Garred LJ","year":"1983","journal-title":"ASAIO J"}],"container-title":["Artificial Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Faor.12526","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aor.12526","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T07:58:04Z","timestamp":1695542284000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/aor.12526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,6]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.1111\/aor.12526"],"URL":"https:\/\/doi.org\/10.1111\/aor.12526","archive":["Portico"],"relation":{},"ISSN":["0160-564X","1525-1594"],"issn-type":[{"value":"0160-564X","type":"print"},{"value":"1525-1594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,6]]}}}